6505--Montelukast Chewable Tablets
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79726R0012
- Agency
- National Acquisition Center Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
-
- Matthew S Poulin matthew.poulin@va.gov (708) 786-5186
Notice details come from SAM.gov. Updated .
About this opportunity
The VA National Acquisition Center intends to issue RFP 36E79726R0012 for Montelukast Sodium Chewable Tablets on or about February 17, 2026, with responses due March 3, 2026. This is an unrestricted procurement with single-award to one responsible offeror capable of providing uninterrupted supply across VA (including Consolidated Mail Order Pharmacies and State Veterans Homes), DoD, Bureau of Prisons, Indian Health Service, and Federal Health Care Center.
The contract period runs one year plus four pre-priced one-year option periods. Products distribute through VA's and DoD's respective Pharmaceutical Prime Vendor Programs. Estimated annual requirements total 29,234 bottles across five line items: 2,625 bottles of 4MG 30-tablet packages; 5,988 bottles of 4MG 90-tablet packages; 4,532 bottles of 5MG 30-tablet packages; 15,887 bottles of 5MG 90-tablet packages; and 202 bottles of 5MG 1,000-tablet packages.
Offerors must provide the exact drug name as it appears on the label and possess a unique NDC number. The successful contractor's label with its unique NDC shall be the only label on the product; contractors may not affix their label over another label. The solicitation will be issued in commercial item format under FAR Part 12. All documents are available electronically at SAM.gov; no paper copies will be provided. Contact Matthew Poulin at matthew.poulin@va.gov or 708-786-5186 with questions.
Notice text
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0012 for an unrestricted procurement for Montelukast Sodium Chewable Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).
VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs.
Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product.
Solicitation # 36E79726R0012 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about February 17, 2026, with a tentative closing date of March 3, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Matthew Poulin. Questions can be e-mailed to Matthew.Poulin@va.gov.
The estimated annual requirements are as follows:
REQUIREMENT DESCRIPTION
ITEM
DESCRIPTION
PACKAGE SIZE (Tablets per Bottle)
TOTAL ESTIMATED ANNUAL USAGE (Bottles)
1
Montelukast NA 4MG Tab, Chew (Unit of Use)
30
2,625
2
Montelukast NA 4MG Tab, Chew (Unit of Use)
90
5,988
3
Montelukast NA 5MG Tab, Chew (Unit of Use)
30
4,532
4
Montelukast NA 5MG Tab, Chew (Unit of Use)
90
15,887
5
Montelukast NA 5MG Tab, Chew
1000
202
Attachments
| File | Type | Posted |
|---|---|---|
| 36E79726R0012_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Montelukast NA Chewable Tablets Effective August 09, 2026 to August 08, 2027 | Award Notice | |
| 6505--Montelukast Chewable Tablets | Solicitation | |
| 6505--Montelukast Chewable Tablets | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity